← back to search

Kun Huang

Shenyang Pharmaceutical University · CN
Area of research
Molecular Biology · Artificial Intelligence
Research interest
Research interests include Bioinformatics and Genomic Networks, Gene expression and cancer classification, AI in cancer detection, and Single-cell and spatial transcriptomics.
h-index
54
citations
10,820
works
681
NIH funding
primary concept
Medicine
email

Recent publications

Identification of Alzheimer's disease subtypes and biomarkers from human multi-omics data using subspace merging algorithm.
2026cited by 0position: contributordoi
Identification of high-risk cells in single-cell spatially resolved transcriptomics data using Diagnostic Evidence GAuge of Single-cells with spatial smoothing.
2026cited by 0position: contributordoi
Novel Computational Pipeline Enables Reliable Diagnosis of Inverted Urothelial Papilloma and Distinguishes It From Urothelial Carcinoma.
2025cited by 1position: contributordoi
Leveraging transcription factor physical proximity for enhancing gene regulation inference.
2025cited by 0position: contributordoi
Deep Transfer Learning Links Benign Glands to Prostate Cancer Progression via Transcriptomics.
2025cited by 0position: contributordoi
A dynamic modeling approach to predict water inflow during tunnel excavation in relatively uniform rock masses
Tunnelling and Underground Space Technology 2024cited by 16position: lastdoi
1q amplification and PHF19 expressing high-risk cells are associated with relapsed/refractory multiple myeloma.
2024cited by 11position: contributordoi
Social and Behavior Factors of Alzheimer's Disease and Related Dementias: A National Study in the U.S.
American Journal of Preventive Medicine 2023cited by 6position: middledoi
Identification and validation of feature genes associated with M1 macrophages in preeclampsia
Aging 2023cited by 4position: middledoi
Identifying 1q amplification and PHF19 expressing high-risk cells associated with relapsed/refractory multiple myeloma
2023cited by 0position: contributordoi
Artificial Intelligence in Omics.
2022cited by 26position: contributordoi
Optimal transport- and kernel-based early detection of mild cognitive impairment patients based on magnetic resonance and positron emission tomography images.
2022cited by 2position: contributordoi
MOGONET integrates multi-omics data using graph convolutional networks allowing patient classification and biomarker identification.
2021cited by 297position: contributordoi
Intron retention-induced neoantigen load correlates with unfavorable prognosis in multiple myeloma.
2021cited by 27position: contributordoi
Evaluating mismatch repair deficiency for solid tumor immunotherapy eligibility: immunohistochemistry versus microsatellite molecular testing
Human Pathology 2021cited by 19position: contributordoi
TSUNAMI: Translational Bioinformatics Tool Suite for Network Analysis and Mining.
2021cited by 14position: contributordoi
BrcaSeg: A Deep Learning Approach for Tissue Quantification and Genomic Correlations of Histopathological Images.
2021cited by 11position: contributordoi
WEVar: a novel statistical learning framework for predicting noncoding regulatory variants
Briefings in Bioinformatics 2021cited by 9position: middledoi
Optimal Transport-Based Early Detection of Mild Cognitive Impairment Patients Based on Magnetic Resonance Images
2021cited by 0position: contributordoi
AI in Medical Imaging Informatics: Current Challenges and Future Directions
IEEE Journal of Biomedical and Health Informatics 2020cited by 654position: middledoi
Computational analysis of pathological images enables a better diagnosis of TFE3 Xp11.2 translocation renal cell carcinoma.
2020cited by 56position: contributordoi
WEVar: a novel statistical learning framework for predicting noncoding regulatory variants
bioRxiv (Cold Spring Harbor Laboratory) 2020cited by 0position: middledoi
A Deep Learning Approach for Tissue Spatial Quantification and Genomic Correlations of Histopathological Images
2020cited by 0position: contributordoi
Integration of molecular features with clinical information for predicting outcomes for neuroblastoma patients.
2019cited by 23position: contributordoi
Correlation Analysis of Histopathology and Proteogenomics Data for Breast Cancer.
2019cited by 22position: contributordoi
Integrative analysis based on survival associated co-expression gene modules for predicting Neuroblastoma patients' survival time.
2019cited by 21position: contributordoi
PTR Explorer: An approach to identify and explore Post Transcriptional Regulatory mechanisms using proteogenomics
2019cited by 1position: middledoi
TSUNAMI: Translational Bioinformatics Tool Suite For Network Analysis And Mining
2019cited by 0position: contributordoi
Proteogenomic Analysis of Surgically Resected Lung Adenocarcinoma
Journal of Thoracic Oncology 2018cited by 31position: middledoi
Imitating Pathologist Based Assessment With Interpretable and Context Based Neural Network Modeling of Histology Images
Biomedical Informatics Insights 2018cited by 12position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

· 19 papers (2019–2026)Jie Zhang · Indiana University School of Medicine9 papers (2019–2026)Zhi Han · Chinese Academy of Sciences5 papers (2019–2021)Raghu Machiraju · The Ohio State University5 papers (2014–2019)Parag Mallick · Palo Alto University4 papers (2017–2019)Arunima Srivastava · The Ohio State University4 papers (2017–2019)Liang Cheng · State Key Laboratory of Chemical Engineering3 papers (2020–2025)Jun Cheng · Shenzhen University3 papers (2020–2021)Tongxin Wang · Fudan University3 papers (2019–2021)Travis S. Johnson · Indiana University Health3 papers (2023–2025)Brian A. Walker · University of Pennsylvania3 papers (2021–2024)Dong Ni · Union Hospital3 papers (2020–2021)Wei Shao · Jiangnan University3 papers (2020–2021)Wei Shao · Hôpital de Morges3 papers (2019–2021)Song‐Hai Shi · McGovern Institute for Brain Research3 papers (2012–2014)Peng Gao · Beijing Chaoyang Emergency Medical Center2 papers (2014–2014)Yunlong Liu · Indiana University School of Medicine2 papers (2020–2021)Yue Wang · Virginia Tech2 papers (2020–2021)Li Chen · University of Florida2 papers (2020–2021)Ye Wang · Io Therapeutics (United States)2 papers (2020–2021)